Skip to main content
. 2022 Sep 1;28(9):1292–1297. doi: 10.14744/tjtes.2022.42347

Table 1.

Features of survived and non-survived patients

Survived n=150 Non-Survived n=5 p


Median (25–75p) Median (25–75p)
Age (months) 65 (25–132) 125 (54–136) 0.49
BIG score 9.2 (6.7–15.8) 30.4 (25.9–32.05) <0.001
Pediatric Trauma Score 8 (6-10) -1 (-1–2) <0.001
Glasgow Coma Scale 12.5 (10–14) 3 (3–3) 0.002
Pediatric Risk of Mortality Score 6 (5–9) 34 (26–45) <0.001
Intraabdominal or intratorasic hemorrhage, n (%) 43 (28.7) 1 (20) 0.6
Intracranial hemorrhage, n (%) 37 (24.7) 2 (40) 0.6
C-reactive protein (mg/dL) 2.8 (1–11.4) 1.3 (1.2–1.7) 0.54
D-Dimer (mcg/L) 3646 (1213–8780) 18451 (13686–36850) 0.03
Albumin (g/dL) 4.25 (3.8–4.5) 2.4 (1.7–2.7) <0.001
Base deficit (meq/L) 3.1 (2.1–5) 12.3 (9.2–13.9) <0.001
International normalized ratio 1.1 (1–1.4) 1.9 (1.8–2.2) 0.002
Lactate dehydrogenase (U/L) 481 (343–756) 478 (390–813) 0.8
Creatinin kinase (U/L) 388 (191–876) 855 (542–1853) 0.13
Procalcitonin (ng/ml) 0.45 (0.12–1.89) 0.12 (0.03–12.06) 0.671
White blood cells (x103/mm3) 15.2 (12.1–19.4) 11.2 (9.6–15.3) 0.26
Platelets (x103/mm3) 283 (223–340) 133 (64–211) 0.015